A live archive of receipt-bound excerpts from company earnings calls. No generated thesis, no recommendation — just the recorded language, its source coordinates, and a direct path into the ticker dossier or live Terminal.来自公司财报电话会的可追溯摘录档案。没有生成式投资结论，也没有推荐——只有原始表述、来源坐标，以及进入个股档案或实时终端的直接入口。
Start free in Terminal免费开始使用终端649 verified call records份已核验电话会记录 · 7788 exact facts条精确事实 · 2026-10-26 → 2026-11-01
Browse the full archive page by page. Search on this page by ticker, period, category, or speaker; every card preview is a verbatim call excerpt.分页浏览完整档案。在本页按代码、期间、分类或发言人搜索；每张卡片预览均为电话会原文摘录。
Showing records 2113–2208 of 6702.显示第 2113–2208 条，共 6702 条。
“During the quarter, we invested $11 million of cash spend for quality system and product-related remediation activities, $11 million on restructuring and integration, and $19 million on CapEx for general maintenance and capacity expansion at our facilities, as well as placement of revenue-generating infusion pumps with customers outside the U.S.”
“With these efficiency improvements and a favorable business mix derived from the greater contribution of commercial revenues and a higher percentage of revenues tied to fixed and T&M contracts, we remain well-positioned to achieve our target of 10-20 basis points adjusted EBITDA margin expansion for the full year, as well as over the longer term.”
“During the quarter, the other segment revenue, net of eliminations, grew 50%, which contributed positively to consolidated gross profit, but also created a mix headwind to our consolidated gross margin percentage of 40 basis points.”
“With our strong execution in the first half of the year, we are reiterating our full year in 2026 revenue and cash burn guidance and remain confident in our growth, margins, and long-term opportunities.”
“Headline revenues were up 24% year-over-year, with strong incremental margins of 46%, that was after some impact from the CAM acquisition.”
“As a result of our second quarter outperformance and improved outlook for the second half of the year, we are raising our 2026 comparable hotel Total RevPAR and RevPAR growth guidance ranges to 4.75%-5.25% over 2025.”
“In the second quarter, Heritage generated record net income of $61.7 million, record diluted earnings per share of $2.05, an annualized return on equity in excess of 45%, and substantial operating cash flow of $166.5 million.”
“Regardless, with the 12-month strip remaining around $70 per barrel WTI, we are confident that our customers will be using higher planning price assumptions this budget season compared to what they used last year, pointing to upstream spending growth in 2027.”
“As a result of our strong first half operating performance and our confidence in the outlook for the remainder of the year, we are increasing our full year 2026 core earnings guidance to a range of $4.60-$4.90 per share.”
“Looking at the full year of 2026, we continue to expect second half revenue to be meaningfully stronger than the first half, driven by strong service and spares orders bookings during the first half of the year that will translate into higher revenue as customers prepare for higher activity levels.”
“At a high level, the way to think about it, before we get into those details next week, is we will have a dozen to 15 different investments that we believe are ones that we could hold for long periods of time that will generate high rates of return based on their structural competitive positions, management teams, and strong levels of earnings growth.”
“I'd like to highlight that ex-China demand for FRUZAQLA continues to grow as well, achieving an overall 40% growth in in-market sales.”
“Total revenue grew by 11%, driven by the premium growth, as well as an increase in services revenue generated from new clients in Exzeo.”
“As a reminder, we had $12.5 million of notified ARR down sell and churn related to the migration and had identified approximately $52 million of additional at-risk ARR, of which we expected to retain $22 million.”
“Encouraged by these exceptional results and our confidence in the outlook for new investment activity, fee income, portfolio yield, and our cost of debt, we are increasing our 2028 adjusted EPS guidance to a range of $3.55-$3.65, up from $3.50-$3.60, and affirming our guidance for adjusted ROE of greater than 17% in 2028.”
“The robust revenue performance resulted in adjusted EBITDA of CHF 329 million, adjusted EBITDA margin of more than 65%, and non-GAAP earnings per share of CHF 2.28, highlighting the strength of our diversified royalty portfolio and the operating leverage that's inherent in our differentiated business model.”
“Following a strong first quarter, we are raising our fiscal 2027 apheresis revenue guidance to low to mid single-digit growth.”
“I want to first ask about replacement versus OE volume expectations for the Q3, which I assume entails sustained OE growth, likely at a lower rate and with less pronounced replacement declines, to get your total volumes flat year-over-year per the outlook.”
“We also continue to be very optimistic about our outlook for organic growth for the second half of 2026, as Jackie will discuss shortly, and remain on track to meet our previously disclosed full year production guidance of 7,500-9,300 GEOs.”
“Given our strong growth through the first half of the year, positive user response to core app improvements and higher than anticipated AI-driven operational leverage, we are raising our full year 2026 outlook today.”
“Importantly, we have successfully mitigated the profitability impact of the changing reimbursement environment under the IRA through disciplined execution across the business, enabling us to generate adjusted EBITDA growth of 23% during the first half of 2026, compared with the first half of 2025.”
“As a result, we expect second half net sales to be down low single digits and adjusted EBITDA to decline when compared to second half of 2025, with the impact more pronounced in the fourth quarter.”
“Military and government service revenue increased 40% compared to Q2 2025 and 20% sequentially, reflecting high demand and increased usage of related services.”
“Turning to slide six, we continue to derive growth through CareScout, which represents a significant long-term opportunity given the growing demand for aging care, including from 70 million baby boomers now aged 62 to 80.”
“Turning to our outlook for 2026, we are raising our full year AFFO per share guidance from $0.80-$0.84 to a new range of $0.82-$0.85, and increasing our gross transaction volume guidance from $250 million-$350 million to a new range of $700 million-$800 million.”
“A fleet of 43 high-quality, modern dry bulk vessels are significant operating leverage combined with low financial leverage, a $10,000 cash flow break-even rate, and $350 million of undrawn revolver availability collectively provide an attractive risk-reward balance for shareholders.”
“In the second quarter, with these low-cost channels underperforming, we increased our investment in acquisitions through higher cost channels, increasing our base of higher lifetime value customers and building a tailwind that we expect to positively impact the coming quarters.”
“Pivoting to financial guidance, Globus Medical reaffirms its full-year 2026 revenue guidance of $3.18 billion-$3.22 billion, and we are increasing our guidance for non-GAAP fully diluted earnings per share to be in the range of $4.95-$5.05, from the previous range of $4.70-$4.80.”
“We've also seen increasing growth in the community this year, with the majority of new sites activated coming from community practices, and now over 90% of our key customers are ordering for two or more sites.”
“Business revenue increased 1% during the second quarter, driven by growth in business data revenue from service upgrades with existing healthcare and education customers.”
“Business revenue increased 1% during the second quarter, driven by growth in business data revenue from service upgrades with existing healthcare and education customers.”
“We expect an adjusted EBITDA of between $61 million to $66 million, 19% growth at the midpoint, and continued margin expansion.”
“We introduced a three-year financial framework targeting 8%-10% organic revenue growth and adjusted EBITDA margins of 14%-16% by fiscal year 2029, with our sights set on achieving top quartile performance over time.”
“Going forward, we believe our carbon business, based on current capacity and market conditions, can deliver over $30 million per year in revenue on a run rate basis, excluding our bank CFR credit sales.”
“We have increased our full year 2026 GAAP net income guidance to a range of $168 million-$175 million, or a range of $1.27-$1.32 per diluted share on annual revenues of $2.95 billion-$3.05 billion, and based on an effective tax rate of approximately 30%, inclusive of known discrete items.”
“Our $11 million revenue beat in Q2 flowed through to an $8 million EBITDA beat, aided by the strong natural operating leverage in our business model, ramp of GeniusIQ, and the initial Legend synergies, which, as we will discuss in a bit, are just getting started.”
“Q1 is our fifth consecutive quarter of double-digit bookings growth, up 11% year-over-year to $1.28 billion, while our revenues also increased 11% year-over-year to $1.34 billion, our fastest growth rate since Gen was created, with broad-based growth across our two segments.”
“We get to the possibility of doing an upsized bond bill at some point and immediately kind of expect to save 450-500 basis points on it, and then use the cash flow in that period to then pay down other debt.”
“Subscription revenue increased to $28.5 million, up 39% year-over-year, driven by the ongoing demand for our condition-specific offerings, particularly weight loss.”
“Looking ahead, we expect third quarter revenue to be in the range of $375 million-$400 million.”
“On margins, we continue to expect full-year gross margin to expand to 50 basis points to 36.5%, with adjusted operating income margin expected to increase approximately 25 basis points to 17.7%, reflecting our continued commitment to self-fund investments for growth.”
“With that $120 million of net acquisitions growing off that low base, even popping that up a little bit, you continue to add top quality real estate, great markets, top MSAs, replaceable rents, and we don't have to sacrifice the quality in any shape, way or form going forward for years and years to come to have outsized growth.”
“If I'm doing my math right here, I think margins were up about 50 basis points year-over-year, but off of a base of when they were maybe kind of down over 600 basis points last quarter when you'd obviously had some challenges in both revenue and costs.”
“Together, these efforts, combined with our strong retention rates, have helped expand our full year adjusted EBITDA margin by roughly 1,400 basis points over a four-year period, from 13% in 2022 to a forecasted 27% this year, based on the increased guidance I will cover shortly.”
“We delivered solid operating performance, generated significant free cash flow, maintained a very strong balance sheet, and advanced the two principal value drivers for next phase of growth, the Séguéla plant expansion and the Diamba Sud Gold Project, which together are key to delivering approximately 60% growth in annual production by mid-2028.”
“Consistent with the objectives outlined in our first quarter earnings call, we reduced leverage and returned net debt-to-equity to our target range of one to 1.25 times.”
“Even as usage trends accelerated through the first half of 2026, our guidance philosophy will remain unchanged as we continue to de-risk large deals due to timing uncertainties and any benefit from cloud usage above contractual commitments.”
“While revenue was at the high end of our expectations, it stepped down sequentially, which was expected and consistent with our guidance, reflecting portfolio optimization associated with the Phoenix operations divestiture as well as the discrete timing of shipments we flagged last quarter and lower F-150 volume tied to the aluminum supply disruption.”
“With the performance of Tubi and FOX One running ahead of expectations, the level of investment in digital-led growth initiatives moderated in fiscal 2026 versus the prior year, and we expect to see continued bottom-line improvement in this portfolio going into fiscal 2027.”
“With the performance of Tubi and FOX One running ahead of expectations, the level of investment in digital-led growth initiatives moderated in fiscal 2026 versus the prior year, and we expect to see continued bottom-line improvement in this portfolio going into fiscal 2027.”
“Diving into Q2 results, we delivered Q2 results above our previously provided guidance, including +34% year-over-year growth in gross revenue, +51% year-over-year growth in gross revenue less network fees, +39% growth in adjusted EBITDA, and $21 million of adjusted free cash flow versus our $10 million guide.”
“All in, the Title business generated adjusted pre-tax Title earnings of $448 million, up 33% over $337 million in the second quarter of 2025, and a 17.8% adjusted pre-tax Title margin in the quarter versus 15.5% in the prior year quarter.”
“I was wondering how you feel about the 10%-15% margin guidance you have, backlog converting $2.2 billion next year, $2.8 billion after that.”
“For AI revenue, we now anticipate full year 2026 growth to be at least 60% year-over-year, up from our prior outlook of more than 40%, reflecting the earlier than forecasted ramps I mentioned a moment ago.”
“Second, while maintaining the growth rates in our medium-term outlook, we are updating our guidance for the second half of the year, which results in full-year guidance for organic revenue to a range of -1% to flat and adjusted operating margins to a range of 31%-31.5%.”
“We averaged a little more than 73,000 MMBtu per day of gas production versus the 70,000 MMBtu per day required at the plant, and we expect to maintain production well in excess of plant requirements and generate continued revenues from excess gas sales in the quarters ahead.”
“Net revenues grew 29% to $197 million, beating our outlook and marking our third straight quarter with 25%+ growth.”
“We expect to maintain our estimated company Action Level risk-based capital, or RBC ratio, above our 400% target.”
“Given that trajectory, we're raising our full year 2026 free cash flow guidance from $6 million-$9 million, up to $12 million-$14 million.”
“When we put it all together, we have high confidence in our plan, and we are reaffirming our long-term adjusted EPS growth target of 6%-8%+ through 2030 off of the 2026 midpoint of $4.24.”
“The results and impact of these AI-enabled capabilities, which are built on our 2024 Machinify acquisition, are at the high end of our expectations, giving us increased confidence in our 2027 outlook.”
“We've inflected Etsy's year-over-year growth trajectory from high single-digit GMS declines in early 2025 to mid single-digit growth anticipated for the full year 2026, a more than 10 percentage point improvement in performance.”
“A result of our first half performance, we are raising our full year revenue guidance to $269 million-$271 million, up from our previous range of $266.5 million-$268.5 million.”
“Listen, I would say that over time, we kind of target free cash flow conversion to adjusted net earnings of around 100%.”
“We experienced a 90-basis-point year-over-year margin decline because of transitory price/cost neutrality and deliberate targeted commercial investments to accelerate growth in our equipment product line.”
“We have also increased our consolidated capital expenditure guidance by $10 million to include the approval of a new power line at Xavantina.”
“With the completion of the business combination with Orla Mining, we enter the second half of 2026 as North America's new senior gold producer with meaningfully greater production, stronger cash flow, and one of the industry's strongest organic growth pipelines.”
“For earnings per share, we expect GAAP diluted EPS to be in the range of $2.33-$2.41 for the quarter, and non-GAAP diluted EPS to be in the range of $3.38-$3.46 for the quarter, producing year-over-year growth of over 11% at the midpoint of the range.”
“On the profit side, we expect the $8 million benefit from the partial tariff refund to be offset by $10 million of full year impact from the increased inflationary environment we are currently facing.”
“On the downside, we saw lower revenue, a decrease of BRL 35.2 million due to the reduced impact of modulation and the impact of curtailment determined by ONS, which rose from 15.7% to 23.7% during the quarter, resulting in an impact of BRL 34.8 million negative.”
“We continue to target customer-supported fleet growth of 10%-15% during 2026, with the majority of additions in the second half of the year.”
“This increase is consistent with our previously announced target of a low double-digit annual dividend growth rate through 2028 and reflects our confidence in the company's ability to fund growth while returning capital to shareholders.”
“According to IMF July 2026 World Economic Outlook update, global growth is projected to slow to 3% in 2026 before recovering to 3.4% in 2027, broadly unchanged cumulatively from April's forecast.”
“Operating income growth of $9.5 million or 20.7% to $55.5 million, and adjusted EBITDA of $70.4 million, with adjusted EBITDA margins improving to 12.2%, a new high watermark for DXP.”
“We are reiterating our full-year 2026 guidance, revenue of $1.95 billion to $2.05 billion, same-store sales of flat to 2%, and net new unit growth of 160 to 190 units.”
“Our Q2 2027 growth outlook is impacted by the tough comparison against last year's elevated 23% growth.”
“and international markets drove system-wide sales growth of 2.6%, excluding the impact of the now ended McDonald's USA partnership from last year.”
“business delivered $1.1 billion in revenue, up 13% from the first quarter, representing strong sequential revenue improvement in areas where the combined DNOW and MRC Global platform gives us the best opportunity to recapture customer activity, gain share, and improve operating leverage.”
“Given the pace of adoption, expanding access, and continued strong execution, we expect Q3 net product revenue to be in the range of $10 million-$12 million.”
“As we think about fleet positioning and the time it takes to get a string of new orders, at this point, if we're in August 2026, barring resales, when could we actually see the turnaround time between placing a vessel order and actually taking delivery of a vessel, a string of newbuild VLCCs?”
“Total commodity revenue was $504 million, equating to approximately $4.23 per MCFE, and adjusted EBITDA was $240 million for the quarter, with our adjusted EBITDA margin at 52%.”
“We generated free cash flow of $279 million with a free cash flow margin of 25%.”
“Turning to 2026 guidance, we are increasing our full-year revenue guidance to range from $104 million-$108 million, which reflects at least a 28% growth in HEPZATO KIT volume over 2025.”
“At more muted levels versus the first half, on the outlook for the second half of 2026, we expect to see continued growth from both our defense and commercial aerospace businesses.”
“With Eaton Mobility, we are targeting $14 billion-$15 billion of sales by 2030, along with meaningfully higher margins and stronger free cash flow generation.”
“net product revenues were $23 million, powered by robust demand and more than 80% of patients on paid prescriptions.”
“Total revenue from supporting cell and gene therapy clinical trials increased 12% to $13.4 million for the quarter as our clients' clinical pipelines advanced and further matured.”
“We expect adjusted funds from operations, or AFFO, which we consider a proxy for our cash flow available for capital allocation decisions such as share repurchases and growth CapEx, such as acquisitions and facility activations, to range from $257.5 million-$271.5 million for 2026.”
“We continue to expect full year free cash flow conversion of 90%-110%, supported by our robust backlog and operating discipline.”
“We continue to expect that operating income growth will outpace sales growth, and our increased guidance reflects 50 basis points-70 basis points of margin expansion in pursuit of a record 19.1%-19.3%.”
“Over the last three years, we grew revenue from less than $1.5 billion to $1.95 billion, expanded EBITDA margins by 300 basis points, nearly doubled adjusted earnings per share, and more than doubled free cash flow, which let us invest in high return opportunities and return capital to shareholders at the same time.”
“With now basically three years in that $50 million-$60 million revenue range and expenses, ±$100 million a year, are you coming to a point where it's not an execution issue, but more a demand issue?”
“The cash balance as of June 30th, 2026, does not include the additional $37 million payment received from Regeneron in July, following the selection of two additional targets under the expanded collaboration.”
“Our outlook now anticipates revenue between $435 million and $445 million, adjusted consolidated EBITDA between $135 million and $140 million, adjusted EBITDA margin between 31% and 31.5%, adjusted diluted EPS between $3.35 and $3.55, overhead expenses between 13.5% and 14% of revenue, adjusted free cash flow between $40 million and $50 million, ending leverage ratio between 3.9 and 4 times.”
“Excluding metered power revenue, which can fluctuate based on customer power consumption and generally has little impact on profitability, revenue totaled approximately $260.2 million and performed in line with our expectations.”
“Based on our cash position at June 30th 2026 and our current plans, we expect our cash to fund operations into the second quarter of 2028.”
Try a ticker, period, category, or a call speaker.请尝试代码、期间、分类或电话会发言人。
This is a transcript-only, historically incomplete publication. Releases, filings, slides, consensus and price reaction are visibly marked as not joined; lower-evidence packets remain held instead of being inferred.这是仅基于电话会文本且历史覆盖尚不完整的发布。新闻稿、披露文件、演示材料、一致预期和股价反应均明确标注为未接入；证据不足的数据包会被暂缓，而非由推断补齐。